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Introduction
Antibiotics can be a lifesaving treatment for children with 
bacterial infections and are the most commonly prescribed 
therapy among all medications given to children.1 However, 
antibiotics can also result in adverse events, drug toxicity 
and detrimental effects on the gut microbiota2,3 and enteric 
immune system.4,5 Furthermore, both at the individual and 
population levels, antibiotic overuse drives the development 
and transmission of antimicrobial resistance.1,6 International 
guidelines for the treatment of childhood illnesses recommend 
antibiotic treatment for diarrhoea with bloody stools and for 
acute lower respiratory tract infections, but not for non-bloody 
diarrhoea and for upper respiratory infections.7,8 Interventions 
to promote rational antibiotic use are critical for preserving the 
effectiveness of available drugs.9–11 Conversely, in low-resource 
settings, the high burden of bacterial causes of diarrhoea in 
children12,13 has led to proposals for antibiotics to be used more 
widely for the treatment of diarrhoea even in the absence of 
dysentery.14–16 Antibiotics may also be a potential intervention 
for malnutrition and environmental enteropathy.17
Differences in antibiotic use practices around the world 
reflect differences in local medication policies, in barriers to 
access to care and in the preferences of health-care providers 
and mothers. The availability of antibiotics without a doctor’s 
prescription varies,6,18 and laws to limit access to antibiotics are 
often poorly enforced.6,19–22 In some settings, drug shortages 
may be a major limiter of antibiotic use.18,23 Cultural prefer-
ences, such as high demand by mothers, also influence patterns 
of antibiotic use.19,22,24,25 Even when health-care providers are 
aware of the appropriate indications for antibiotics, there can 
be differences between knowledge and practice.26,27
Objective To describe the frequency and factors associated with antibiotic use in early childhood, and estimate the proportion of diarrhoea 
and respiratory illnesses episodes treated with antibiotics.
Methods Between 2009 and 2014, we followed 2134 children from eight sites in Bangladesh, Brazil, India, Nepal, Pakistan, Peru, South Africa 
and the United Republic of Tanzania, enrolled in the MAL-ED birth cohort study. We documented all antibiotic use from mothers’ reports at 
twice-weekly visits over the children’s first two years of life. We estimated the incidence of antibiotic use and the associations of antibiotic 
use with child and household characteristics. We described treatment patterns for diarrhoea and respiratory illnesses, and identified factors 
associated with treatment and antibiotic class.
Findings Over 1 346 388 total days of observation, 16 913 courses of antibiotics were recorded (an incidence of 4.9 courses per child per 
year), with the highest use in South Asia. Antibiotic treatment was given for 375/499 (75.2%) episodes of bloody diarrhoea and for 4274/9661 
(44.2%) episodes of diarrhoea without bloody stools. Antibiotics were used in 2384/3943 (60.5%) episodes of fieldworker-confirmed acute 
lower respiratory tract illness as well as in 6608/16742 (39.5%) episodes of upper respiratory illness. Penicillins were used most frequently 
for respiratory illness, while antibiotic classes for diarrhoea treatment varied within and between sites.
Conclusion Repeated antibiotic exposure was common early in life, and treatment of non-bloody diarrhoea and non-specific respiratory 
illnesses was not consistent with international recommendations. Rational antibiotic use programmes may have the most impact in South 
Asia, where antibiotic use was highest.
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Many studies of antibiotic use have 
been conducted in various health-care 
settings22,28–30 and in cross-sectional 
community-based surveys.31–35 Nev-
ertheless, high-resolution, systematic 
assessments of antibiotic use in prospec-
tive, observational cohort studies have 
not been reported. MAL-ED (Etiology, 
Risk Factors, and Interactions of Enteric 
Infections and Malnutrition and the 
Consequences for Child Health and De-
velopment Project) was a multisite birth 
cohort study conducted in eight sites in 
different countries of South America, 
sub-Saharan Africa and Asia.36 This 
study included community-based sur-
veillance for antibiotic use and provides 
an opportunity to compare antibiotic 
use patterns across diverse low-resource 
sites. We aimed to describe the fre-
quency of antibiotic use by children in 
the first two years of life; determine the 
characteristics associated with antibiotic 
use; and estimate the proportions of di-
arrhoea and respiratory illness episodes 
treated with antibiotics, as reported by 
mothers in the MAL-ED study.
Methods
The MAL-ED study design36 and cohort 
characteristics have been previously de-
scribed.37 Briefly, the study was conducted 
at sites in eight different countries: Dhaka 
(Bangladesh), Fortaleza (Brazil), Vellore 
(India), Bhaktapur (Nepal), Naushahro 
Feroze (Pakistan), Loreto (Peru), Venda 
(South Africa) and Haydom (United 
Republic of Tanzania). Healthy children 
were enrolled between November 2009 
and February 2012 within 17 days of 
birth. Two-year follow-up for all enrolled 
children was completed in February 
2014. The criteria for enrolment were 
children without severe or chronic condi-
tions, enteropathy or hospitalization, and 
enrolment weight ≥ 1500 g.
Surveillance for illnesses and anti-
biotic use was conducted twice per week 
by fieldworkers at home visits until the 
child was two years of age or was lost 
to follow-up. Children were referred to 
locally available care, generally a local 
clinic, when ill.38 Fieldworkers asked the 
mother (or other caregiver) to report all 
oral or injected antibiotics given to their 
child on each day since the previous visit 
and to show the medication packaging 
to confirm the antibiotic and class. If 
packaging were not available, fieldwork-
ers documented antibiotic use from any 
paperwork provided by health-care pro-
viders. When a mother reported seeking 
medical care or medications for their 
child, fieldworkers recorded separately 
prescribed medicines in medical care 
report forms. Socioeconomic character-
istics were assessed through twice-yearly 
questionnaires. 
To validate mothers’ reports of an-
tibiotic use, we randomly selected 4409 
of the fieldworkers’ medical care report 
forms (including at least 200 records of 
antibiotics per site) and extracted all 
antibiotic information. We assessed the 
concordance between mother-reported 
antibiotic use and antibiotic use as docu-
mented on the medical care report forms.
All sites received ethical approval 
from their respective government, local 
institution and collaborating institution 
ethical review boards. We obtained 
informed consent from the mother of 
each child.
Data and definitions
We counted distinct antibiotic courses 
when separated by at least two antibiot-
ic-free days. The results were insensitive 
to an alternative definition using three 
antibiotic-free days; only 580 (3.4%) 
of 16 913 courses occurred within 
three days. The duration of antibiotic 
courses was defined as the total num-
ber of days on which antibiotics were 
received, assuming antibiotics were 
not received on missed surveillance 
days (2.0% of all surveillance days). A 
child was classified as exposed to high 
antibiotic use if he or she received more 
than or equal to the median number of 
courses received by children at his or her 
study site in the first two years of life.
Fig. 1. Incidence of antibiotic use in the first two years of life by study site among 2134 




















































MAL-ED: Etiology, Risk Factors, and Interactions of Enteric Infections and Malnutrition and the 
Consequences for Child Health and Development Project.
Notes: Incidence was calculated using restricted quadratic splines for age.41 The total number of antibiotic 
courses was 16913. Number of antibiotic courses at study sites: Dhaka (Bangladesh) n = 4062; Fortaleza 
(Brazil) n = 235; Vellore (India) n = 1730; Bhaktapur (Nepal) n = 1065; Naushahro Feroze (Pakistan) n = 5142; 
Loreto (Peru) n = 2447; Venda (South Africa) n = 534; Haydom (United Republic of Tanzania) n = 1698.
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We based illness definitions on 
Integrated Management of Child-
hood Illness guidelines.7 Non-bloody 
diarrhoea was defined as mother’s 
reports of three or more loose stools in 
24 hours. Bloody diarrhoea was defined 
as mother’s report of at least one loose 
stool with visible blood.38 Respiratory 
illness was defined as cough or shortness 
of breath. Acute lower respiratory tract 
illness was defined as cough or shortness 
of breath with a rapid respiratory rate 
determined by fieldworkers (defined by 
the average of two measurements per 
day that were: > 60 breaths per minute 
when the child was < 2 months old; > 50 
breaths per minute at age 2 months to 
1 year; and > 40 breaths per minute at 
age ≥ 1 year).38 If antibiotics were taken 
during any day of the illness episode, 
the episode was classified as treated with 
antibiotics.
Socioeconomic status was de-
scribed using the child’s average score 
on the WAMI index based on: household 
access to improved water and sanitation; 
wealth measured by eight household 
assets; mother’s education; and monthly 
household income.39 Crowding was de-
fined as the mean number of people per 
room. Improved water and sanitation 
were defined following World Health 
Organization (WHO) guidelines.40
Analysis
We calculated the incidence of antibiotic 
use as the number of courses divided by 
the number of at-risk surveillance days. 
The incidence over the first two years of 
life was estimated using a pooled logis-
tic regression model with a restricted 
quadratic spline41 for age with seven 
knots. Cumulative incidence curves 
were constructed non-parametrically as 
the inverse of Kaplan–Meier estimates.
We adjusted for the following: study 
site; the proportion of days ill with 
diarrhoea, cough, fever, vomiting and 
fieldworker-confirmed acute lower re-
spiratory infection in the first two years 
of life; and the interaction between this 
proportion and study site. To estimate 
the associations between overall an-
tibiotic use and child and household 
characteristics we used linear regression 
for the proportion of days on antibiotics 
and log-binomial regression for risk of 
high antibiotic use.
We then described the frequency of 
treatment for diarrhoea and respiratory 
illnesses. We estimated the associations 
between the characteristics of those 
episodes and antibiotic treatment using 
log-binomial regression, adjusting for 
study site and other episode character-
istics. We also accounted for correlations 
between episodes in the same child 
using generalized estimating equations 
with a robust variance estimator. Among 
treated episodes, we used these log-
binomial models to estimate the asso-
ciations between antibiotic class chosen 
and episode and child characteristics.
Results
Antibiotic use
We included 2134 children in the 
MAL-ED cohort who were surveyed 
for antibiotic use for any illness on at 
least one day in the first two years of 
life. Over a mean of 631 days of obser-
vation per child (1 346 388 total days of 
observation), 16 913 courses (100 342 
total days) of antibiotics were recorded. 
This corresponded to an overall average 
antibiotic use of 4.9 courses per child per 
year. The median duration of antibiotic 
courses was 5 days (interquartile range: 
3 to 7). Extended courses of antibiotics 
were rare; only 53 (0.3%) courses had 
durations longer than 1 month.
The magnitude of use differed 
across the eight sites (Fig. 1). Frequency 
of use was highest at the site in Naushah-
ro Feroze (an average of 11.9 courses per 
child-year) and in Dhaka (10.3 courses 
per child-year). In contrast, the use was 
≤ 1.0 course per child-year in Fortaleza 
and Venda, respectively. Antibiotic use 
peaked between 6 and 12 months of 
age in all sites, and peaked again in the 
second year of life in Loreto, Vellore 
and Fortaleza.
Early antibiotic use was common 
even in the first 6 months of life. In 
Dhaka and Naushahro Feroze, more 
Fig. 2. Cumulative incidence of first antibiotic use in the first two years of life by study 
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Naushahro Feroze
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Dhaka Haydom Loreto Vellore
Bhakapur
MAL-ED: Etiology, Risk Factors, and Interactions of Enteric Infections and Malnutrition and the 
Consequences for Child Health and Development Project.
Notes: The black dotted line indicates age at each study site where 50% of children received at least 
one course of antibiotics. Incidence was calculated using restricted quadratic splines for age.41 The total 
number of antibiotic courses was 16913. Number of antibiotic courses at study sites: Dhaka (Bangladesh) 
n = 4062; Fortaleza (Brazil) n = 235; Vellore (India) n = 1730; Bhaktapur (Nepal) n = 1065; Naushahro Feroze 
(Pakistan) n = 5142; Loreto (Peru) n = 2447; Venda (South Africa) n = 534; Haydom (United Republic of 
Tanzania) n = 1698.
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than 98.0% of children followed until 
at least age 6 months had received 
antibiotics by that age (Fig. 2). More 
than half of children had received an-
tibiotics by age 6 months in Bhaktapur, 
Haydom, Loreto and Vellore. Children 
in Naushahro Feroze were exposed 
to antibiotics on 32 345 (17.5%) of 
152 176 observed child-days in the first 
two years of life, which corresponds 
to more than 4 months of cumulative 
antibiotic treatment. This proportion 
was even higher in the first 6 months of 
life (9383 child-days; 19.5%). The days 
of treatment in the first two years of life 
was lower in other sites, ranging from 
1823 (1.3%) of 138 060 observed child-
days in Fortaleza to 25 663 (15.5%) of 
140 237 child-days in Dhaka.
A total of 1741 children (81.6%) 
remained under surveillance until 
at least two years of age. More boys 
(543/888; 61.2%) than girls (436/853; 
51.1%) received at or above the site-
specific median number of antibiotic 
courses (Table 1). Adjusting for the 
proportion of days ill, the risk of high 
antibiotic use was 13% greater among 
boys compared with girls (risk ratio, 
RR: 1.13; 95% confidence interval, CI: 
0.99 to 1.28). The association between 
antibiotic use and sex was driven by 
Naushahro Feroze (RR: 1.44; 95% 
CI: 1.02 to 2.03) and Bhaktapur (RR: 
1.37; 95% CI: 0.9 to 1.97), with no as-
sociations at the other country sites. 
Socioeconomic status and income 
were associated with small increases in 
overall antibiotic use (Table 1).
Diarrhoea treatment
A total of 10 161 diarrhoea episodes 
were recorded among 1201 of the 
children; 4649 (45.8%) episodes were 
treated with antibiotics (Table 2). The 
use of antibiotics for the treatment of 
diarrhoea varied across sites from 10.6% 
of 180 episodes in Fortaleza to 59.1% 
of 3212 episodes in Naushahro Feroze.
Mothers reported bloody stools in 
499 (4.9%) diarrhoea episodes. A higher 
proportion of episodes of bloody diar-
rhoea (375; 75.2%) were treated with 
antibiotics than those without bloody 
stools (4274/9661; 44.2%; Table 3). 
Adjusting for study site and other 
characteristics of illness episodes, the 
risk ratio of antibiotic treatment was 
1.50 (95% CI: 1.40 to 1.64) for episodes 
with bloody stools. Greater age at epi-
sode, duration, number of loose stools, 
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. vomiting were all independently associ-
ated with an increased risk of antibiotic 
treatment.
Slightly fewer diarrhoea episodes 
in girls (2178/4897; 44.5%) were treated 
with antibiotics than those in boys 
(2471/5264; 46.9%; adjusted RR: 0.95; 
95% CI: 0.90 to 1.00; Table 3). Higher 
socioeconomic status was associated 
with an increase in treatment (RR: 1.19; 
95% CI: 1.10 to 1.29).
The antibiotic class chosen for 
diarrhoea treatment varied across and 
within sites (Fig. 3). Diarrhoea episodes 
in the sites in Dhaka and Loreto were 
most often treated with macrolides, 
while metronidazole was the most 
common class for diarrhoea treatment 
in Bhaktapur, Haydom and Naushahro 
Feroze. Episodes in Fortaleza and Venda 
were mainly treated with sulfonamides 
and penicillins. Fluoroquinolones were 
rarely used for diarrhoea treatment in 
most sites; their use was most frequent 
in the South Asian sites of Dhaka and 
Vellore.
Bloody diarrhoea episodes (75/499) 
were twice as likely to be treated with 
fluoroquinolones compared with non-
bloody episodes (462/9661) (RR ad-
justed for study site: 2.01; 95% CI: 1.63 
to 2.48). Bloody episodes were also 20 
to 40% more likely to be treated with 
macrolides, cephalosporins and met-
ronidazole, and were less likely to be 
treated with penicillins (51/499 bloody 
episodes and 870/9661 non-bloody epi-
sodes; RR adjusted for study site: 0.57; 
95% CI: 0.44 to 0.75).
Diarrhoea episodes among children 
from higher socioeconomic status were 
more likely than those occurring among 
children of lower socioeconomic status 
to be treated with metronidazole (RR 
per 0.5 difference in WAMI score: 1.17; 
95% CI: 1.06 to 1.30) and macrolides 
(RR: 1.14; 95% CI: 0.93 to 1.39) and less 
likely to be treated with penicillins (RR: 
0.79; 95% CI: 0.62 to 1.00). The child’s 
sex did not affect choice of antibiotic 
class for diarrhoea.
Respiratory illness treatment
Of 20 685 respiratory illness episodes 
among 1672 children, 8992 (43.5%) 
episodes were treated with antibiotics. 
Use of antibiotics was lowest in Fortaleza 
(35.5% of 431 episodes) and highest 
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Fieldworkers confirmed 3943 
(19.1%) episodes of respiratory illnesses 
had signs of acute lower respiratory tract 
illness. A higher proportion of these 
episodes (2384; 60.5%) were treated with 
antibiotics than were episodes of upper 
respiratory illness (6608/16742; 39.5%; 
Table 3). Adjusting for site, the risk ratio 
of antibiotic treatment for acute lower 
respiratory tract illness compared to 
upper respiratory illness was 1.53 (95% 
CI: 1.47 to 1.59).
Respiratory illnesses were signifi-
cantly more likely to be treated if the 
episode was of longer duration, and if 
independently there was fever, short-
ness of breath or rapid respiratory 
rate reported (Table 3). Treatment did 
not vary by age. Similar to diarrhoea 
treatment, respiratory illness episodes 
in girls were slightly less likely to be 
treated with antibiotics (4199/10 019; 
41.9%) than those in boys (4793/10 666; 
44.9%); after adjusting for study site and 
episode characteristics, the risk ratio was 
0.94 (95% CI: 0.91 to 0.98). Higher so-
cioeconomic status was also associated 
with a significant but small increase in 
treatment (adjusted RR: 1.10; 95% CI: 
1.03 to 1.17).
The antibiotic class used for re-
spiratory illness treatment was fairly 
consistent across sites, with penicillins 
the most frequently used drug in all sites 
except Naushahro Feroze (Fig. 4). Ceph-
alosporins were also often chosen in the 
South Asian sites of Naushahro Feroze, 
Vellore and Dhaka, while macrolides 
were also highly used in Dhaka. Because 
penicillins were almost exclusively used 
at several sites, a cross-site analysis of 
antibiotic classes by type of respiratory 
illness was not possible.
Among antibiotic-treated respira-
tory illnesses, higher socioeconomic 
status was significantly associated with 
more use of macrolides (RR per 0.5 
difference in WAMI score: 1.30; 95% 
CI: 1.09 to 1.56) and cephalosporins 
(RR: 1.48; 95% CI: 1.30 to 1.69) and 
correspondingly less use of penicil-
lins (RR: 0.93; 95% CI: 0.85 to 1.01). 
There was no association between sex 
and antibiotic class used for respira-
tory illness.
Validation of mothers’ reports
Overall concordance between antibiot-
ics reported in the medical care report 
forms and caregiver-reported antibiotic 
use was high 1737 (85.8%) of 2042 forms 
analysed (Box 1).
Discussion
Despite substantial heterogeneity, the 
frequent and early use of antibiotics in 
these low-resource settings is striking. 
In the most extreme case, children at the 
site in Pakistan were exposed to antibiot-
ics on approximately one-fifth of days 
in their first 6 months of life. Antibiotic 
usage rates were higher in most sites 
Fig. 3. Relative frequency of antibiotic drug classes used in 4649 treated diarrhoea 

































Bhakapur Dhaka Fortaleza Haydom Loreto Naushahro
Feroze
Vellore Venda All sites
Penicillins Sulfonamides Macrolides Metronidazole
Cephalosporins Fluoroquinolones Unknown/other
MAL-ED: Etiology, Risk Factors, and Interactions of Enteric Infections and Malnutrition and the 
Consequences for Child Health and Development Project.
Notes: Distinct antibiotic courses were counted when separated by at least two antibiotic-free days. 
Courses are included in multiple class categories if more than one drug class was given. Number of 
treated diarrhoea episodes at study sites: Dhaka (Bangladesh) n = 972; Fortaleza (Brazil), n = 19; Vellore 
(India) n = 248; Bhaktapur (Nepal) n = 326; Naushahro Feroze (Pakistan) n = 1899; Loreto (Peru) n = 792; 
Venda (South Africa) n =  71; Haydom (United Republic of Tanzania) n =  322; all sites n = 4649. 
Fig. 4. Relative frequency of antibiotic drug classes used in 8992 treated respiratory 





































Bhakapur Dhaka Fortaleza Haydom Loreto Naushahro
Feroze
Vellore Venda All sites
Penicillins Sulfonamides Macrolides Metronidazole
Cephalosporins Fluoroquinolones Unknown/other
MAL-ED: Etiology, Risk Factors, and Interactions of Enteric Infections and Malnutrition and the 
Consequences for Child Health and Development Project.
Notes: Distinct antibiotic courses were counted when separated by at least two antibiotic-free days. 
Courses are included in multiple class categories if more than one drug class was given. Number of 
treated respiratory illness episodes at study sites: Dhaka (Bangladesh) n = 2575; Fortaleza (Brazil), n = 153; 
Vellore (India) n = 817; Bhaktapur (Nepal) n = 600; Naushahro Feroze (Pakistan) n = 2163; Loreto (Peru) 
n = 1490; Venda (South Africa) n =  316; Haydom (United Republic of Tanzania) n = 878; all sites n = 8992.
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than that reported for children aged 3 
to 24 months in the United States of 
America in 2010 (0.9 to 1.7 courses per 
child-year).42 Higher antibiotic use in 
the South Asian sites compared with 
the African and South American sites 
is explained by more episodes of diar-
rhoea and respiratory illnesses as well as 
a higher proportion of illness episodes 
treated in this region. Differences in 
the proportion of episodes treated may 
be explained by site-specific treatment 
guidelines and availability of antibiotics. 
For example, access to antibiotics is less 
restricted in the South Asian sites,6,19 
while drug shortages are common in 
South Africa.23
Illness symptoms were strong 
drivers of antibiotic treatment for both 
diarrhoea and respiratory illnesses, 
demonstrating that treatment decisions 
were made rationally according to illness 
severity. However, many episodes of 
non-bloody diarrhoea (44.2%) and non-
acute-lower respiratory-tract illness 
(39.5%) were treated with antibiotics, 
contrary to international recommenda-
tions against routine use of antibiotics 
for non-bloody diarrhoea8 and upper 
respiratory tract infections.43,44 These 
percentages were higher than the overall 
antibiotic treatment frequency of 37% 
reported for 17 693 paediatric inpatients 
from 226 hospitals in 41 countries.45 
Because only 4.9% of diarrhoea epi-
sodes in our study were bloody, almost 
all antibiotic treatment of diarrhoea 
(4274/4649 episodes; 91.9%) was for 
non-bloody episodes, which is inconsis-
tent with treatment guidelines. Similarly, 
only one-fifth of respiratory infections 
were fieldworker-confirmed acute lower 
respiratory tract infection and therefore 
73.5% (6608/8992) treated episodes of 
respiratory illnesses were inconsistent 
with treatment guidelines.
Conversely, while antibiotic treat-
ment is recommended for dysen-
tery8 and acute lower respiratory tract 
infection,7 only 75.2% of diarrhoea 
episodes with bloody stools and 60.5% 
of fieldworker-confirmed acute lower 
respiratory illness episodes were treated 
with antibiotics. Choice of antibiotic 
class for diarrhoea treatment was also 
inconsistent, suggesting diarrhoea 
treatment guidelines were not clearly 
followed. Fluoroquinolones and mac-
rolides are recommended by WHO for 
the treatment of dysentery,8 but metro-
nidazole was given most frequently, in 
more than one-third of dysentery cases. 
Presence of bloody stools was associated 
with a higher probability of appropriate 
treatment with fluoroquinolones and 
macrolides, but these drugs were still 
underused.
The lower frequency of treatment 
among girls compared with boys after 
adjusting for illness burden and severity 
indicates that social factors also likely 
played a role in treatment decisions. So-
cioeconomic status was associated with 
frequency of antibiotic treatment as well 
as the antibiotic classes chosen for both 
diarrhoea and respiratory illnesses. In-
creased macrolides and cephalosporins 
use compared to less penicillins use 
among families with higher socioeco-
nomic status corresponds to higher prices 
for these drugs, which may be a barrier to 
access for low-income families.
This analysis provides a comprehen-
sive description of antibiotic use across 
eight low-resource country settings, 
using data reported on every day of the 
first two years of life, a method which is 
superior to that of retrospective surveys. 
Using data on diarrhoea and respira-
tory illness symptoms, we were able to 
document treatment frequency and to 
comment on compliance with interna-
tional guidelines. Mothers’ reports of 
antibiotic use ensured that we counted 
antibiotics taken (not only prescribed) 
and captured antibiotic use from all 
sources, including those that would 
not be included in clinic or prescrip-
tion records, e.g. those from alternative 
health-care providers. We found high 
concordance between mothers’ reports 
and medical care report forms, as has 
been previously described,46 suggesting 
mothers’ reporting was reliable.
The study was limited by incom-
plete details of antibiotic use, including 
specific drugs given and their formula-
tions, prophylactic versus treatment 
use, how and where antibiotics were 
obtained, and the antibiotic class for the 
courses classified as unknown or other. 
We also inferred indication for treat-
ment by concurrent illnesses and symp-
toms reported, without direct reports 
of the cause of treatment, which limits 
our ability to determine conclusively the 
appropriateness of treatment.
Overall, antibiotic use early in life 
was common, and we found evidence 
of both overuse for the treatment of 
non-bloody diarrhoea and upper respi-
ratory tract illnesses, and underuse for 
the treatment of bloody diarrhoea and 
acute lower respiratory tract infection. 
We also found evidence for sex and 
class differences in access to medicines. 
Rational antibiotic use programmes and 
promotion of illness-specific treatment 
guidelines may have the greatest impact 
in South Asia, where antibiotic use was 
highest. Planning of intervention studies 
involving antibiotic treatment needs to 
address complex, site-specific variations 
in use and consider the potentially high 
baseline frequency of antibiotic use. 
Further inquiry into the consequences 
of this highly prevalent exposure among 
children will be an important contri-
bution to our understanding of child 
development in low-resource settings. ■
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Box 1. Validation of mothers’ reports of antibiotic use in the MAL-ED cohort study, 
2009–2014
Medical care report forms were identified for 13 393 (79.2%) of all 16 913 antibiotic courses, 
and the validation sample yielded 2024 antibiotic prescriptions from 4409 forms. Concordance 
between use of antibiotics reported in the medical care report forms and mother-reported 
antibiotic use was high; on 1737 (85.8%) of forms the antibiotics corresponded with mothers’ 
reports on the same day. The concordance between antibiotic classes was also high: 95.1% 
(849/893) for penicillins, 94.8% (329/247) for cephalosporins, 86.6% (265/306) for macrolides, 
85.2% (213/250) for metronidazole, 73.4% (177/241) for sulphonamides and 70.0% (42/60) for 
fluoroquinolones.
Bull World Health Organ 2017;95:49–61| doi: http://dx.doi.org/10.2471/BLT.16.17612358
Research
Antibiotic use in low-resource settings Elizabeth T Rogawski et al.
صخلم
ةيقابتسا ةيبارتأ ةسارد :نادلب نيماث في ينماع نم رغصلأا لافطلأل ةيويلحا تاداضلما ءاطعإ
 في  لافطلأل  ةيويلحا  تاداضلما  ءاطعإ  ةيرتو  فصو  ضرغلا
 ةبسن  ريدقتو  ،كلذب  ةطبترلما  لماوعلاو  ةركبلما  ةيرمعلا  مهلحارم
 تلجوع يتلا سيفنتلا زاهلجا ضارمأو لاهسلإاب ةباصلإا تلااح
.ةيويلحا تاداضلماب
 ةعباتمب  2014  و  2009  يماع  ينب  ام  ةترفلا  في  انمق  ةقيرطلا
 لابينو دنلهاو ليزابرلاو شيدلاغنب في عقاوم نيماث نم ًلافط 2134
 نيذلا  ،ةدحتلما  اينازنت  ةيروهجمو ايقيرفأ  بونجو ويربو ناتسكابو
 .MAL-ED  ديلاولماب  ةصالخا  ةيبارتلأا  ةسارد  في  مهليجست  مت
 تاغلاب  نم  ةيويلحا  تاداضلما  لوانت  تلااح  عيجم  قيثوتب  انمقو
 ينماعلا لاوط ينترم ثدتح يتلا ةيعوبسلأا تارايزلا في تاهملأا
 تاداضلما  لوانت  تلااح  ددع  ريدقتب  انمق  ماك  .لفطلل  ينلولأا
 لفطلا صئاصخ عم ةيويلحا تاداضلما لوانت ينب طباورلاو ةيويلحا
 ةباصلما  تلااحلل  جلاعلا  طمانلأ  اًفصو  انمدق  كلذبو  .ةسرلأاو
 ةئفب ةطبترلما لماوعلا انددحو ،سيفنتلا زاهلجا ضارمأو لاهسلإاب
.يويلحا داضلماو جلاعلا
 ،ةظحلالماو دصرلا مايأ لياجمإ نم 1346388  رادم لىع جئاتنلا
 ةيويلحا  تاداضلماب  ةيجلاع  ةطخ  16913  دادعإ  ليجست  مت
 ،)دحاولا  ماعلا  في لفط لكل ةيجلاع ةطخ 4.9  دادعإ لدعمب(
 لىعلأا  وه  ةيويلحا  تاداضلما  لوانت  لدعم  نأ  ةظحلام  عم
 لدعمب  ةيويلحا  تاداضلماب  جلاعلا  ءاطعإ  مت  .ايسآ  بونج  في
 يومدلا  لاهسلإاب  ةباصلما  تلااحلل  )% 75.2(  499/375
 لاهسلإاب ةباصلما تلااحلل )% 44.2( 9661/4274 لدعمبو
 في  ةيويلحا  تاداضلما  لوانت  متو  .يومد  زارب  لوزن  نود  نم
 ىودعب ةدكؤلما ةباصلإا تلااح نم )% 60.5( 3943/2348
 16742/6608  في  كلذكو  دالحا  ةيلفسلا  ةيسفنتلا  ةانقلا
 ةيسفنتلا  ةانقلا  ىودعب  ةدكؤلما  ةباصلإا  تلااح  نم  )% 39.5(
 في  ينلسنبلا  ةيودأ  ءاطعإ  مت  .ينيناديلما  ينلماعلا  ىدل  ةيولعلا
 تنيابت  مانيب  ،سيفنتلا  زاهلجا  ضارمأ  جلاعل  نايحلأا  مظعم
 عقاولما  ينبو  لخاد  لاهسلإا  جلاعل  ةيويلحا  تاداضلما  تائف
.ةفلتخلما
 اًعئاش  ةيويلحا  تاداضملل  رركتلما  ضرعتلا  ناك  دقل  جاتنتسلاا
 يومدلا  يرغ  لاهسلإا  جلاع  نكي  لمو  ،ةركبم  ةيرمع  ةلحرم  في
 تايصوتلا  عم  اًقسانتم  ةددحلما  يرغ  سيفنتلا  زاهلجا  ضارمأو
 ققح ام يه ةيقطنلما ةيويلحا تاداضلما لوانت جمارب لعلو .ةيلودلا







方法 在 2009 年至 2014 年期间，我们对巴基斯坦、巴
西、秘鲁、孟加拉国、南非、尼泊尔、坦桑尼亚联合
共和国以及印度八个地区报名参加营养不良和肠道疾







结 果 经 过 共 1 346 388 天 的 观 察， 我 们 记 录
了 16 913 个抗生素使用案例（每名儿童每年平均使
用 4.9 次），其中抗生素在南亚的使用率最高。 出血
性腹泻的抗生素治疗比例为 375/499 (75.2%)，无血便











Utilisation d’antibiotiques chez les enfants de moins de deux ans dans huit pays: une étude de cohorte prospective
Objectif Décrire la fréquence et les facteurs associés à l’utilisation 
d’antibiotiques chez les jeunes enfants et estimer la proportion 
d’épisodes de diarrhée et de maladies respiratoires traités avec des 
antibiotiques.
Méthodes De 2009 à 2014, nous avons suivi 2134 enfants qui 
participaient à l’étude de cohorte de naissance MAL-ED sur huit sites 
en Afrique du Sud, au Bangladesh, au Brésil, en Inde, au Népal, au 
Pakistan, au Pérou et en République-Unie de Tanzanie. Nous avons 
noté l’utilisation de tous les antibiotiques déclarés par les mères lors de 
consultations bi-hebdomadaires pendant les deux premières années 
de vie des enfants. Nous avons estimé l’incidence du recours aux 
antibiotiques ainsi que les associations entre utilisation d’antibiotiques 
et caractéristiques des enfants et des foyers. Nous avons décrit les 
habitudes de traitement de la diarrhée et des maladies respiratoires 
et avons identifié les facteurs associés aux traitements et aux classes 
d’antibiotiques.
Résultats  Sur  1  346  388  jours  d ’obser vat ion  au  tota l , 
16 913 traitements aux antibiotiques ont été enregistrés (incidence 
de 4,9 traitements par enfant et par an), la plus forte utilisation 
ayant été observée en Asie du Sud. Un traitement antibiotique a été 
administré pour 375/499 (75,2%) épisodes de diarrhée sanglante et 
pour 4274/9661 (44,2%) épisodes de diarrhée sans présence de sang 
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dans les selles. Des antibiotiques ont été utilisés pour 2384/3943 
(60,5%) épisodes de maladie aiguë des voies respiratoires inférieures 
confirmée par un professionnel sur le terrain ainsi que pour 
6608/16 742 (39,5%) épisodes de maladie des voies respiratoires 
supérieures. Les pénicillines étaient les plus fréquemment utilisées 
pour combattre les maladies respiratoires, tandis que les classes 
d’antibiotiques utilisées pour traiter la diarrhée variaient selon les 
sites et au sein d’un même site.
Conclusion L’exposition répétée aux antibiotiques à un jeune âge était 
courante et le traitement de la diarrhée sans présence de sang dans les 
selles et de maladies respiratoires non spécifiques ne respectait pas les 
recommandations internationales. C’est en Asie du Sud, où l’usage des 
antibiotiques était le plus important, que les programmes d’utilisation 
rationnelle des antibiotiques pourraient avoir le plus fort impact. 
Резюме
Прием антибиотиков детьми младше двух лет в восьми странах: проспективное когортное 
исследование
Цель Описать частоту употребления антибиотиков в раннем 
детстве и факторы, связанные с этим, и определить долю случаев 
диареи и заболеваний дыхательных путей, для лечения которых 
использовались антибиотики.
Методы В период между 2009 и 2014 годами авторы осуществляли 
наблюдение за 2134 детьми из восьми локаций в Бангладеш, 
Бразилии, Индии, Непале, Объединенной Республике Танзания, 
Пакистане, Перу и Южной Африке, участвующих в исследовании 
возрастной группы MAL-ED. Все случаи приема антибиотиков 
были задокументированы со слов матерей работниками местного 
центра, совершавшими визит два раза в неделю в течение 
первых двух лет жизни ребенка. Авторы определили частотность 
приема антибиотиков и связи между приемом антибиотиков 
детьми и особенностями домашнего хозяйства. Были описаны 
модели лечения диареи и заболеваний дыхательных путей, а 
также определены факторы, связанные с лечением и классом 
антибиотиков.
Результаты За 1 346 388 суммарных дней наблюдения 
б ы л о  з а р е г и с т р и р о в а н о  1 6  9 1 3  к у р с о в  л е ч е н и я 
антибиотиками (частотность составила 4,9 курса на ребенка 
в год), большая доля которых пришлась на Южную Азию. 
Лечение антибиотиками было прописано в 375 из 499 случаев 
диареи с кровью (75,2%) и в 4274 из 9661 случая диареи без 
кровавых примесей (44,2%). Антибиотики применялись в 2384 
из 3943 случаев острого заболевания нижних дыхательных 
путей (60,5%), подтвержденного работниками местного центра, а 
также в 6608 из 16 742 случаев заболевания верхних дыхательных 
путей (39,5%). Чаще других для лечения заболеваний дыхательных 
путей использовались пенициллины, в то время как класс 
антибиотиков для лечения диареи различался как в пределах 
одной локации, так и между локациями.
Вывод В раннем возрасте было распространено неоднократное 
воздействие антибиотиков, а лечение диареи без следов крови и 
неспецифических заболеваний дыхательных путей проводилось 
не в соответствии с международными рекомендациями. 
Программы рационального использования антибиотиков, 
возможно, оказывают наибольшее влияние в Южной Азии, где 
процент применения антибиотиков был наиболее высок. 
Resumen
El uso de antibióticos en niños menores de dos años en ocho países: un estudio prospectivo de cohortes
Objetivo Describir la frecuencia y los factores relacionados con el 
uso de antibióticos en la primera infancia y estimar la proporción de 
los episodios de diarrea y enfermedades respiratorias tratados con 
antibióticos.
Métodos Entre 2009 y 2014, se realizó el seguimiento de 2 134 niños 
de ocho lugares en Bangladesh, Brasil, India, Nepal, Pakistán, Perú, 
la República Unida de Tanzania y Sudáfrica inscritos en el estudio de 
cohortes en el nacimiento MAL-ED. Se documentó el uso de todos los 
antibióticos de los informes de las madres en las visitas dos veces por 
semana a lo largo de los dos primeros años de vida de los niños. Se 
estimó la incidencia del uso de antibióticos y las asociaciones del uso de 
antibióticos con características familiares y con niños. Se describieron los 
patrones de tratamiento para la diarrea y las enfermedades respiratorias, 
y se identificaron los factores relacionados con las clases de tratamientos 
y de antibióticos.
Resultados De un total de 1 346 388 días de observación, se 
registraron 16 913 tratamientos con antibióticos (una incidencia de 4,9 
tratamientos por niño al año), siendo el mayor uso en el sur de Asia. 
Se empleó tratamiento con antibióticos en 375/499 (75,2%) episodios 
de diarrea hemorrágica y en 4 274/9 661 (44,2%) episodios de diarrea 
sin deposiciones hemorrágicas. Se usaron antibióticos en 2 384/3 943 
(60,5%) episodios de enfermedad respiratoria aguda de las vías bajas 
confirmadas por los investigadores, así como en 6 608/16 742 (39,5%) 
episodios de enfermedad respiratoria de las vías altas. Las penicilinas 
se usaron más frecuentemente para las enfermedades respiratorias, 
mientras que los antibióticos para el tratamiento de la diarrea variaron 
entre los distintos lugares.
Conclusión La exposición repetida a antibióticos fue común en los 
primeros años de vida, y el tratamiento de diarrea no hemorrágica y 
de enfermedades respiratorias no específicas no fue coherente con las 
recomendaciones internacionales. Los programas de uso racional de 
antibióticos pueden tener el mayor efecto en el sur de Asia, donde el 
uso de antibióticos fue el más alto.
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